Adenosine A2b Receptor 抗体 (AA 233-282)
-
- 抗原 See all Adenosine A2b Receptor (ADORA2B) 抗体
- Adenosine A2b Receptor (ADORA2B)
-
抗原表位
- AA 233-282
-
适用
- 人, 豚鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Adenosine A2b Receptor antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- Human ADORA2B
- 预测反应
- Percent identity by BLAST analysis:
- 纯化方法
- Immunoaffinity purified
- 免疫原
-
Synthetic peptide located between aa233-282 of human ADORA2B (P29275, NP_000667). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon (100%), Monkey, Marmoset, Horse (92%), Rabbit (85%), Galago (84%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product ADORA2B Primary Antibody
-
-
- 应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Distilled water
- 浓度
- Lot specific
- 缓冲液
- Lyophilized from PBS with 2 % sucrose
- 注意事项
- Avoid repeat freeze-thaw cycles.
- 储存条件
- 4 °C,-20 °C
- 储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- 抗原
- Adenosine A2b Receptor (ADORA2B)
- 别名
- ADORA2B/Adenosine A2B Receptor (ADORA2B 产品)
- 别名
- si:dkey-13b16.1 antibody, ADORA2B antibody, LOC606745 antibody, LOC100220469 antibody, ADORA2 antibody, A2BAR antibody, A2BR antibody, A2b antibody, AA2BR antibody, AI480866 antibody, AI605384 antibody, adenosine A2b receptor antibody, adenosine A2B receptor antibody, adora2b antibody, ADORA2B antibody, Adora2b antibody
- 背景
-
Name/Gene ID: ADORA2B
Subfamily: Adenosine
Family: GPCR
Synonyms: ADORA2B, ADORA2, A2b receptor, Adenosine A2b receptor, Adenosine a2b, Adenosine receptor A2b, A2b adenosine receptor - 基因ID
- 136
- NCBI登录号
- NP_000667
- UniProt
- P29275
- 途径
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-